2m 2m 2m 2m 2m 2m 2m
PROTALIX BIOTHPS (PLX)
NYSE
$2.70+$0.06 (+2.16%)
Price as of Sep 11, 2026 8:00 PM EDT- $212.7MMarket Cap
- 45.86%1-Year Change
- BiotechnologyIndustry
PROTALIX BIOTHPS (PLX)
$2.70+$0.06 (+2.16%)
PLX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.64 | ||
Change | -$0.09 (-3.30%) | ||
Open | $2.74 | ||
High | $2.75 | ||
Low | $2.62 | ||
Previous Close | $2.73 | ||
Volume | 646,807 | ||
30-Day Average Volume | 823,524 | ||
1-Week Change | -1.12% | ||
1-Month Change | 8.64% | ||
1-Year Change | 45.86% | ||
3-Year Change | 50.86% | ||
5-Year Change | 76.00% | ||
Fundamentals | |||
Shares Outstanding | 80.6M | ||
Total Assets | $110.3M | ||
Market Cap | $212.7M | ||
Enterprise Value | $185.3M | ||
Period: QTR TTM FY | |||
Revenue | $19.8M | ||
Net Income | $3.8M | ||
Free Cash Flow | -$11.0M | ||
EBIT | $4.9M | ||
EBITDA | $5.3M | ||
Net Working Capital | $60.8M | ||
EPS | $0.05 | ||
Enterprise Value/EBITDA | 35 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 3 | ||
P/E | 53 | ||
PEG | -1 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 12/20/2019 | ||
Earnings & Revenue